Roblitinib | Interleukin Related interleukin-related.com

Product Name :
Roblitinib

Search keywords :
Roblitinib

drugId :
null

Target Vo:
Fibroblast growth factor receptor 4

Target Vo Short Name :
FGFR4

Moa_Name:
Fibroblast growth factor receptor 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Everest Medicines Ltd

Active Indication_Name:
Carcinoma, Hepatocellular

In Active Indication_Name:
Solid tumours

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glutathione Peroxidase 4 Rabbit pAb Autophagy
NOX2 Antibody manufacturer
GRB2 Antibody: GRB2 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to GRB2. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts